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Symbiotic gut microorganisms (microbiome) interact closely with the mammalian host’s
metabolism and are important determinants of human health. Here, we decipher the complex
metabolic effects of microbial manipulation, by comparing germfree mice colonized by a human
baby ﬂora (HBF) or a normal ﬂora to conventional mice. We perform parallel microbiological
proﬁling, metabolic proﬁling by
1H nuclear magnetic resonance of liver, plasma, urine and ileal
ﬂushes, and targeted proﬁling of bile acids by ultra performance liquid chromatography–mass
spectrometry and short-chain fatty acids in cecum by GC-FID. Top-down multivariate analysis of
metabolic proﬁles reveals a signiﬁcant association of speciﬁc metabotypes with the resident
microbiome. We derive a transgenomic graph model showing that HBF ﬂora has a remarkably
simple microbiome/metabolome correlation network, impacting directly on the host’s ability to
metabolize lipids: HBF mice present higher ileal concentrations of tauro-conjugated bile acids,
reduced plasma levels of lipoproteins but higher hepatic triglyceride content associated with
depletionofglutathione.Thesedataindicatethatthemicrobiomemodulatesabsorption,storageand
the energy harvest from the diet at the systems level.
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Introduction
The symbiotic gut microbiome exerts a strong inﬂuence on the
metabolic phenotype of the mammalian host and participates
in extensive microbial–mammalian co-metabolism (Dunne,
2001; Xu and Gordon, 2003; Backhed et al, 2005; Eckburg et al,
2005; Holmes and Nicholson, 2005; Nicholson et al, 2005; Gill
et al, 2006; Martin et al, 2006; Nicholson, 2006; Turnbaugh
et al, 2006). Gut microbial composition is now known to vary
signiﬁcantly in obese animal (Turnbaugh et al, 2006) and
human (Ley et al, 2006) populations, and recent studies have
shown that the exact state of the gut microbial ecology and
metabolic activities may be of fundamental importance in the
control of caloriﬁc absorption (Xu et al, 2003; Backhed et al,
2004) and in the development of insulin resistance and
nonalcoholic fatty liver disease in high-fat-diet experiments
(Dumas et al, 2006). We know that the symbiotic gut
microbiome acts as an extended genome (Lederberg, 2000)
and has evolved to exert control on a number of important
mammalian metabolic regulatory functions (Dunne, 2001;
Pereira and Gibson, 2002; Xu and Gordon, 2003; Xu et al,
2003; Backhed et al, 2004, 2005; Holmes and Nicholson, 2005;
Nicholsonetal,2005;Dumasetal,2006;Gilletal,2006;Martin
et al, 2006; Sonnenburg et al, 2006). Gut microbes extensively
co-metabolize bile acids and these have mammalian endocrine
functions (Houten et al, 2006; Watanabe et al, 2006).
The integrated metabolism of the bile acid pools in
mammals is a good example of the complex transgenomic
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symbionts as summarized in Figure 1. Bile acids are
synthesized from cholesterol in the liver by a multi-enzyme
coordinated process (Palmeira and Rolo, 2004) and are crucial
for the absorption of dietary fats and lipid-soluble vitamins in
theintestine(Staggersetal,1982).Bileacidsalsohavearolein
maintainingtheintestinalbarrierfunctiontopreventintestinal
bacterial overgrowth and translocation (Lorenzo-Zuniga et al,
2003; Ogata et al, 2003), as well as invasion of underlying
tissues by enteric bacteria (Ogata et al, 2003). In addition,
abnormal bile acid proﬁles are indicative of various hepato-
gastrointestinal diseases, such as dietary fat malabsorption
and gallstone formation (Chace, 2001; Ijare et al, 2005) and
might have an essential role in regulating obesity or type II
diabetes (Houten et al, 2006; Watanabe et al, 2006). Many
so-called secondary bile acids (deoxycholic, lithocholic,
hyodeoxycholic and o-muricholic acids) can be regarded
as examples of mammalian-microbiotal co-metabolism
(Nicholson et al, 2005) and have different metabolic fates
via enterohepatic recirculation (Nicholson et al, 2004). This is
part of what we term the microbiome–host metabolic axis,
which we deﬁne here for the ﬁrst time as ‘the multi-way
exchange and co-metabolism of compounds between the host
organism and the gut microbiome resulting in transgenomi-
cally regulated secondary metabolites, which have biological
activity in both host and microbial compartments’. Under-
standing the effects of bacterial metabolism on the balance of
bile acids in enterohepatic recirculation is a major challenge
owing to the implications of microbiota in fat absorption, lipid
metabolism, drug therapeutic or toxic effects as well as direct
effects within the gastrointestinal tract and its contents (Van
et al, 2002). In this regard, recent advances in microbial and
metabolic proﬁling now enable the multi-compartment study
of bile acids and their effect on intermediary metabolism.
The application of high-resolution
1H nuclear magnetic
resonance (NMR) spectroscopy of bioﬂuids and tissues
coupled with multivariate statistical methods is a well-
established tool for untargeted metabolic proﬁling (Nicholson
and Wilson, 1989; Nicholson et al, 2002, 2005; Wang et al,
2005). Hyphenated chromatographic-mass spectrometric
methods such as ultra-performance liquid chromatography–
mass spectrometry (UPLC–MS)-based proﬁling techniques
havealsobeenrecentlyusedeffectivelyforfunctionalgenomic
discrimination (Plumb et al, 2005; Wilson et al, 2005). Lately,
LC–MS has been shown to be a sensitive and quantitative
method of analysis for identiﬁcation of major bile acids in
urine and plasma (Mims and Hercules, 2003, 2004). Histori-
cally, bile acid analysis has been hindered by difﬁculties in
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Figure 1 Metabolism and synthesis of the major bile acids in mouse. Key: Color denotes family of bile acids, that is, primary bile acids synthesized in liver in black,
secondary bile acids synthesized in liver and processed by microﬂora in green and tertiary bile acids synthesized in liver, processed by microﬂora and re-metabolized in
liver through enterohepatic recirculation in orange. Conjugation with taurine and glycine is colored in blue and red respectively. Key intermediates in the pathway are
colored in gray.
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in a highly complexmatrix. We have now developedand show
here for the ﬁrst time an enhanced bile-acid-targeted proﬁling
method using UPLC–MS, which gives superior chromato-
graphic resolution and sensitivity (Wilson et al, 2005; Plumb
et al, 2006) and greatly aids the study of bile acid metabolism.
In the present study, the complex metabolic response of the
host to perturbation of its enteric microbiota at the systems
level by integration of metabolic data from many compart-
ments was investigated. The aim of the study is to assess the
effects of the induction of a nonadapted microﬂora in a murine
model (human baby ﬂora (HBF)) on the host metabolism
by comparison with animals colonized with a natural
gut microﬂora (conventional), the result of a long period of
co-evolution. An additional group of germfree mice, naturally
re-conventionalized, was used as a control to investigate the
speciﬁc effects related to the re-establishment of a ﬂora in
previously germfree mice. Here, we have integrated the effects
of modulation of the microbiome in mouse models on major
bile acids co-metabolism through targeted metabolic proﬁling,
and characterized the consequences of this intervention at the
systems level through parallel untargeted metabolic proﬁling,
multivariate and graph modeling. Here, we show a signiﬁcant
association of speciﬁc metabotypes and changes of the gut
microbiome between mice colonized naturally with a conven-
tional microﬂora or colonized with a deﬁned microbial
population derived from human host in a pathogen-free
environment, that is, HBF. This study brings further evidence
that gut microﬂora is adapted to each host and that gut
microﬂorainﬂuences thehost’ssystemiclipid metabolism and
energy balance through modiﬁcation of bile acid metabolism
and eventually impacts on the host’s health.
Results
Gut bacterial composition and fecal content
of short-chain fatty acids
Microbiologicalproﬁleswereusedtoassessthestageofbacterial
development during re-conventionalization and colonization
with an HBF. The terminal composition of the fecal microbiota
is detailed in Table I. Using a two-tailed Mann–Whitney test,
we showed that after 32 days of natural re-conventionalization,
the mice have similar microbial composition in feces as con-
ventional animals, although their levels of Bacteroides and
Enterobacteria were higher (Table I). The HBF mice had
markedlydifferentgutmicrobiotacharacterizedbyanimportant
population of Clostridium and higher levels of Bacteroides and
Enterobacteria as those observed in re-conventionalized mice
when compared to conventional mice (Table I).
The fecal content of individual animals was investigated
using gas-chromatography–ﬂame-ionization-detection (GC–
FID) to identify and quantify some major bacterial short-chain
fatty acids (SCFAs), namely acetate, propionate, isobutyrate,
n-butyrate, n-valerate and isovalerate. Although lactate
changes were expected, they were not in fact measured. The
results presented in Table II are given in mmol/g of dry fecal
content, and as mean7s.d. for each group of mice, and were
assessed using a two-tailed Mann–Whitney test. The produc-
tion of SCFAs by the gut microbiota of re-conventionalized
mice was similar to that of conventional mice, except that the
latter has higher levels of acetate. These SCFAs were found in
lower concentrations and in different proportions in HBF mice
(Table II). In particular, a higher proportion of propionate
(24.574%) and a lower proportion of n-butyrate (4.273.4%)
were observed in HBF mice (controls were 10.271.2 and
11.173.4%, respectively).
1H NMR spectroscopy of mouse plasma, urine,
liver and ileal ﬂushes
Examples of typical
1H NMR spectra of urine,
1H CPMG NMR
spectra of liver and plasma from an HBF mouse, and
1H NMR
spectra of ileal ﬂushes from HBF and conventional mice are
shown in Figure 2 and were assigned according to literature
(Nicholson et al, 1995; Tugnoli et al, 2004; Wang et al, 2005),
and conﬁrmed by selected
1H-
1H correlation spectroscopy
Table I Microbial species counts in mouse feces at the end of the experiment
Groups/
log10 CFU
Conventional
(N¼10)
Re-conventional
(N¼10)
HBF-L. paracasei
(N¼7)
Lactobacilli 6.471.5 5.972.5 7.170.4
Enterobacteria 6.571.0 7.870.7** 9.170.4***
a
Biﬁdobacteria 7.071.2 7.871.4 7.570.7
Staphylococcus 4.870.7 4.771.0 5.870.4
C. perfringens o2 o2 7.070.9***
a
Bacteroides 8.370.4 9.170.6** 9.570.9***
Log10 of CFU (colony-forming unit) given per gram of wet weight of feces. Data
are presented as mean7s.d. The average values for the re-colonized group were
compared to the conventional animals: *signiﬁcant difference at 95%
conﬁdence level, **signiﬁcant difference at 99% conﬁdence level, ***signiﬁ-
cant difference at 99.9% conﬁdence level.
aSigniﬁcant difference at 99.9% conﬁdence level was observed when compared
to the re-conventionalized animals.
Table II Short-chain fatty acid content in the cecum from the different groups
SCFAs\microbiota Acetate Propionate Isobutyrate Butyrate Isovalerate Valerate
Conventional 179.1743.5
(73.773.5)
24.475.3
(10.271.2)
3.170.5
(1.370.2)
27.1711.7
(11.174.3)
4.771.3
(270.4)
4.271
(1.770.4)
Re-conventional 136.6751.4*
(6774.2**)
26.576.4
(14.573.7***)
3.370.8
(1.770.4**)
27.5713
(12.174.3)
4.671.2
(2.570.8)
4.571.2
(2.270.5*)
HBF-L. paracasei 34.479.9***
(65.973.1***)
12.874***
(24.574***)
0.670.1***
(1.270.3**)
1.970.9***
(4.273.4***)
1.770.9***
(3.371.4***)
0.470.1***
(0.970.5**)
Data are presented in mmol/g of dry feces and are presented as means7s.d. The relative composition in short-chain fatty acids in percentage of total content. The
average values for the re-colonized group were compared to the conventional animals: *signiﬁcant difference at 95% conﬁdence level, **signiﬁcant difference at 99%
conﬁdence level, ***signiﬁcant difference at 99.9% conﬁdence level.
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1H-
1H total correlation spectroscopy
(TOCSY) (Bax and Davis, 1985) two-dimensional (2D) NMR
experiments on single sample as well as selective statistical
total correlation spectroscopy (STOCSY) (Cloarec et al, 2005a)
experiments on multiple samples. In particular, NMR spectro-
scopy detects a wide range of amino acids, metabolism
intermediates, organic acids, membrane components, satu-
rated and unsaturated triglycerides and fatty acids, ketone
bodies, N-acetyl and O-acetyl-glycoproteins (Table III). Indo-
leacetylglycine (IAG), phenylacetylglycine (PAG), trimethyl-
amine (TMA), trimethylamine-N-oxide(TMAO) and dimethyl-
glycine (DMG) were also identiﬁed in urine. Using NMR, ﬁve
bileacidspecieswereassignedunambiguouslyinilealﬂushes,
that is, b-muricholic (bMCA), tauro-b-muricholic (TbMCA),
cholic (CA), taurocholic (TCA) and tauroursodeoxicholic
(TUDCA) acids.
1H NMR spectra of pure compound showed
that the
1H NMR chemical shifts of C-18, C-19 and C-21 methyl
groups were characteristic for the determination of indivi-
dual bile acid levels. However, this method is of limited
use for probing complex mixtures and for differentiating
conjugated from unconjugated forms of bile acids in such
mixtures.
1H NMR spectral complementary data sets from plasma,
urine, liver tissue or ileal ﬂushes were analyzed using
orthogonal partial least squares discriminant models
(O-PLS-DA) (Trygg and Wold, 2003) to maximize the discrimi-
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Figure 2 Typical 600MHz
1H NMR spectra.
1H CPMG NMRspectra of plasma(A)andintact liver tissue (B), and
1H NMR spectrum of urine(C)froman HBF mouse,
and
1HNMRspectraofilealﬂushesfromHBF(D)andconventionalmice(E).Thespectraoftheurineandilealﬂushesweremagniﬁed6and10timesrespectivelyinthe
aromatic region(d5.2–8.5) compared to the aliphaticregion (d 0.7–4.5). Theliver regions d5.2–5.4 and5.4–8.5were magniﬁed4and 8times respectively. Theplasma
regions d 5.2–5.4 and 5.4–8.5 were magniﬁed 4 and 10 times respectively. Keys to the ﬁgures are given in Table III.
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explained to gut ﬂora changes (Figure 3). The characteristics of
the models generated are summarized in Table IV. O-PLS-DA
revealed signiﬁcant variations in the metabolic proﬁles
from plasma, liver and urine between conventional and
re-conventionalized animals (Table IV). Re-conventionalized
Table III Table of assignment of the metabolites in plasma, liver, urine and ileal ﬂushes
Key Metabolites Moieties d
1H (p.p.m.) and multiplicity
1 Isoleucine aCH, bCH, gCH3, dCH3 3.65(d), 1.95(m), 0.99(t), 1.02(d)
2 Leucine aCH, bCH2, dCH3, dCH3 3.72(t), 1.96(m), 0.91(d), 0.94(d)
3 Valine aCH, bCH, gCH3 3.6(d), 2.26(m), 0.98(d), 1.04(d)
4 Ethanol CH2, bCH3 3.65(q), 1.18(t)
53 - D-hydroxybutyrate CH, CH2, gCH3,C H 2 4.16(dt), 2.41(dd), 1.20(d), 2.31(dd)
6 Lactate aCH, bCH3 4.11(q), 1.32(d)
7 Alanine aCH, bCH3 3.77(q), 1.47(d)
8 Arginine aCH, bCH2, gCH2, dCH2 3.76(t), 1.89(m), 1.63(m), 3.23(t)
9 Lysine aCH, bCH2, gCH2, dCH2, eCH2 3.77(t), 1.89(m), 1.72(m), 1.47(m), 3.01(t)
10 Acetate CH3 1.91(s)
11 Threonine aCH, bCH2, gCH3 3.59(d), 4.25(m), 1.32(d)
12 Proline aCH, bCH2, gCH2, dCH2 4.11(t), 2.02(m)–2.33(m), 2.00(m), 3.34(t)
13 Glutamate aCH, bCH2, gCH2 3.75(m), 2.08(m), 2.34(m)
14 Methionine aCH, bCH2, gCH2, dCH3 3.78(m), 2.14(m), 2.6(dd), 2.13(s)
15 Lipids CH3, (CH2)n, CH2-C¼C, CH2-C¼O,
¼C-CH2-C¼, -CH¼CH-
0.89(m), 1.27(m), 2.0(m), 2.3(m), 2.78(m), 5.3(m)
16 Glutamine aCH, bCH2, gCH2 3.77(m), 2.15(m), 2.44(m)
17 Citrate CH2(2), CH2(1) 2.55(d), 2.65(d)
18 Pyruvate CH3 2.41(s)
19 Aspartic acid aCH, bCH2 3.89(m), 2.68(m), 2.82(m)
20 Asparagine aCH, bCH2 3.90(m), 2.86(m) 2.94(m)
21 Creatine N-CH3,C H 2 3.03(s), 3.92(s)
22 Glutathione CH2,C H 2, S-CH2, N-CH, CH 2.17(m), 2.55(m), 2.95(m), 3.83(m), 4.56(m),
23 Choline N-(CH3)3, OCH2, NCH2 3.2(s), 4.05(t), 3.51(t)
24 Phosphorylcholine N(CH3)3, OCH2, NCH2 3.22(s), 4.21(t), 3.61(t)
25 GPC N-(CH3)3, OCH2, NCH2 3.22(s), 4.32(t), 3.68(t)
26 Taurine N-CH2, S-CH2 3.26(t), 3.40(t)
27 Glycine CH2 3.55(s)
28 N-acetyl-glycoproteins
(Nac)
CH3 2.04(s)
29 O-acetyl-glycoproteins CH3 2.08(s)
30 Trimethylamine-N-oxide
(TMAO)
CH3 3.26(s)
31 Tyrosine CH, CH 7.16(dd), 6.87(dd)
32 Phenylalanine 2,6-CH, 3,5-CH, 4-CH 7.40(m), 7.33(m), 7.35(m)
33 Tryptamine 4-CH, 7-CH, 2-CH, 6-CH, 5-CH, CH2,C H 2 7.70(d), 7.52(d), 7.34(s) 7.29(t), 7.21(t), 3.35(t), 3.18(t)
34 Glycogen Ring protons, CH 3.35–4.0(m), 5.38–5.45(m)
35 a-Glucose 1-CH 5.24(d)
36 Scyllo-inositol OH 3.34(s)
37 Indoleacetyl-glycine (IAG) 4-CH, 7-CH, 2-CH, 5-CH, 6-CH, CH2,C H 2 7.64(d), 7.55(d), 7.35(s) 7.28(t), 7.19(t), 3.82(s), 3.73(s)
38 Phenylacetyl-glycine (PAG) 2,6-CH, 3,5-CH, 7-CH, 10-CH 7.43(m), 7.37(m), 3.75(d), 3.68(s)
39 3-Hydroxy-isovalerate CH3 1.21(s)
40 Creatinine CH3,C H 2 3.06(s), 4.06(s)
41 Phosphocreatine CH3,C H 2 3.05(s), 3.95(s)
42 Isobutyrate CH3, CH 1.11(d), 3.02(m)
43 a-Ketoisovalerate CH3, CH 1.13(d), 3.02(m)
44 Butyrate CH3,C H 2,C H 2 0.90(t), 2.16(t), 1.56(m)
45 a-Keto-isocaproate CH3, CH, CH2 0.94(d), 2.10(m), 2.61(d)
46 Kynurenine CH, CH, CH, CH, CH, CH 4.16(t), 3.72(d), 7,89(d), 6.82(t), 7.43(t), 6.89(d)
47 Uridine CH, CH, CH, CH, CH, CH, CH2,C H 2 7.87(d), 5.92(d), 5.9(s), 4.36(t), 4.24(t), 4.14(q), 3.92(dd),
3.81(dd)
48 Formate CH 8.45(s)
49 Fumarate CH 6.53(s)
50 Citrulline CH, CH2,C H 2,C H 2 3.76(t), 3.15(q), 1.88(m), 1.52(m)
51 2-Oxoglutarate CH2,C H 2 3.01(t), 2.45(t)
52 b-Alanine CH2,C H 2 3.19(t), 2.56(t)
53 Dimethylglycine (DMG) CH2 2.93(s)
54 Trimethylamine (TMA) CH3 2.91(s)
55 Inosine 2-CH,8-CH,20-CH,40-CH,50-CH,CH2,CH 2 8.34(s), 8.24(s), 6.1(d), 4.44(t), 4.28(q), 3.92(dd), 3.85(dd)
56 Putative glycolipid (U1) CH3,C H 2, — 0.89(m), 1.27(m), 1.56(m), 1.68(m), 2.15(m), 2.25(m),
3.10(m), 3.55(m), 3.60(m)
57 p-Toluyl derivative (U2) CH3,C H 2,C H 2,C H 2 2.38(s), 7.31(d), 7.26(d), 5.42(m)
58 Unknown (U3) — 0.37(t), 0.66(m), 0.74(m), 0.90(m), 1.15(m), 1.35(m), 2.24(m)
59 Unknown (U4) — 3.49(s), 1.14(d)
60 Glycerol C2-H, CH2,C H 2 3.91(m), 3.64(m), 3.56(m)
s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublet; dt, doublet of triplet.
Microbiome–mammalian metabolic interactions
F-PJ Martin et al
& 2007 EMBO and Nature Publishing Group Molecular Systems Biology 2007 5HBF plasma
HBF Liver
HBF Urine β-Alanine
+
–
5 4.5 3.5 2.5 1.5
0
0
0
0.7
0.9
r
2
r
2
0
0.7
r
2
r
2
δ1H 432
5 4.5 3.5
U1
U1
U1
3-hydroxy
-isovalerate
U4
U4 I PAG
Nac
IAG
Tryptamine PAG
7 7.4 7.8
2.5 1.5 δ1H 432
3.5 2.5 1.5 δ1H 432
3.5 2.5 1.5 δ1H 432
Glycerol
Glycogen
Glycogen
Gln Choline
Choline
Acetate
Acetate
0.9
Pyruvate
Lipid
Lipid
Lipid
Lipid Lipid
Lys, Asp, Lys, Arg
Asn Gsh, Gln
Lipid
Conventional plasma
Conventional liver
Conventional urine
Conventional ileal fushes
HBF ileal fushes
Taurine
Taurine-conjugated to bile acids
TUDCA
CH and CH2 of ring
TCA
TβMCA
CA
GPC
C
o
v
a
r
i
a
n
c
e
+
–
C
o
v
a
r
i
a
n
c
e
+
–
C
o
v
a
r
i
a
n
c
e
+
–
C
o
v
a
r
i
a
n
c
e
GPC
GPC A
B
C
D
Microbiome–mammalian metabolic interactions
F-PJ Martin et al
6 Molecular Systems Biology 2007 & 2007 EMBO and Nature Publishing Groupmice had higher levels of plasma GPC and choline, lower
urinaryconcentrations of guanidinoacetate and lower levels of
liver glycogen (data not shown).
Signiﬁcant and predictive discrimination of plasma, liver,
urine and ileal ﬂushes between conventional and HBF mice
was achieved using O-PLS-DA, as denoted by high Q
2Yvalues
(Table IV). The corresponding coefﬁcient plots show the
key metabolites in plasma, liver, urine and ileal ﬂushes
that contribute to the separation (Figure 3). Decreases in
levels of lipoproteins and pyruvate, and increased levels of
GPC, choline, acetate and glutamine were observed in the
plasma of HBF mice when compared to conventional animals
(Figure 3A and Supplementary Figure 1). The liver of HBF
mice also showed higher levels of triglycerides and lower
concentrations of glycogen, lysine, arginine, asparagine,
aspartate, glutamine and glutathione (Figure 3B and Supple-
mentary Figure 1). Urinary proﬁles of HBF mice showed lower
levels of PAG, tryptamine and an unknown metabolite (U1),
and higher levels of b-alanine, 3-hydroxy-isovalerate, N-acetyl
signals from glycoproteins and a putative glycolipid as
discussed earlier (Figure 3C). Differences in the ileal ﬂushes
were also characterized with higher levels of TbMCA and
lower levels of CA and TUDCA (Figure 3D).
UPLC–MS analysis and ileal content in bile acids
To complement the bile acid proﬁling achieved by NMR, we
also analyzed ileal ﬂushes using UPLC–MS. Typical negative
ion chromatograms for the bile acids detected in the ileal ﬂush
of a conventional mouse are shown in Figure 4. A total of 14
bileacidswereidentiﬁedbycomparisonwithaseriesof22bile
acid standards. Three additional bile acid components,
identiﬁed as U1 (m/z¼453.2, RT¼2.70), U2 (m/z¼437.2,
RT¼4.44) and U3 (m/z¼491.2, RT¼1.53), were also observed.
Unconjugated muricholic and cholic acids with mass to charge
ratio of m/z¼408.2 were detected at m/z¼453.2 due to the
formation of a formate adduct (45Da).
The relative bile acid compositions in ileal ﬂushes from the
different groups are given in Table V, and are shown as
mean7s.d. of the percentage of the total bile acid content.
UPLC–MS analysis showed that conventional and re-conven-
tionalized mice had speciﬁc bile acid proﬁles—14 bile acids
were identiﬁed, the most abundant species being CA, TCA,
TbMCA and TUDCA. HBF animals showed lower diversity in
their bile acid composition, predominantlycontaining TbMCA
and TCA as well as CA, aMCA, bMCA, TCDCA, TUDCA and
putative unknown bile acid U3.
A comparison of concentrations of bile acids obtained from
HBF re-colonized mice with those from conventional mice
using an O-PLS-DA strategy revealed that conventional mice
showed lower amounts of taurine conjugates such as TbMCA
and TCA, and a higher amount of CA, which is in agreement
with the observations obtained by
1H NMR spectroscopy
(Figure5A). Aweakdiscriminationwasalsoobtained between
conventional and re-conventionalized animals (Figure 5B),
with the latter showing lower levels of CDCA and GCA, and
higher concentrations of TbMCA.
Effect of major bile acids on tissue-speciﬁc
metabolic proﬁles
The effect of TCA and CA on the enterohepatic recirculation
was assessed by OPLS regression, using the NMR-based
metabolic proﬁles from intact liver tissues and ileal luminal
content as X input and CA (or TCA) levels obtained by UPLC–
MS as Y (Figure 6). The
1H NMR metabolic proﬁles obtained
from ileal ﬂushes (Figure 6B and D) show a marked
anticorrelation between TCA and CA, these two major bile
acids operating as ‘anchor’ metabolites. There is a positive
correlation between conjugated taurine and taurine-conju-
gated bile acids, that is, TCA and TbMCA. This cluster of
conjugated species is anticorrelated to free species, that is, CA
and free taurine, consistent with a bacterial deconjugation of
bile acids in the ileum. In the liver (Figure 6A and C), the
situation is reversed, with TCA (CA) being correlated (anti-
correlated) with free taurine, highlighting the fact that the
conjugation process is restricted by the available amount of
taurine (substrate).
Integration of correlations between bile acids
and fecal ﬂora
A novel correlative analysis was performed to investigate the
cross-compartment connections between fecal ﬂora and bile
acids in the intestinal lumen. Bipartite graphs were used to
visualize correlations (above a given cutoff) between fecal
bacteria and bile acids (see Materials and methods and
Figure 7). Conventional and HBF mice show very different
bile acid/fecal ﬂora correlation networks (Figure 7A and B).
Figure 3 O-PLS-DA coefﬁcient plots derived from
1H NMR spectra. O-PLS-DA coefﬁcient plots derived from
1H NMR CPMG spectra of plasma (A),
1H MAS NMR
CPMG spectra of liver (B) and
1H NMR spectra of urine (C) and ileal ﬂushes (D) indicating discrimination between conventional (negative) and HBF-colonized mice
(positive).TheO-PLS-DAcoefﬁcientplotsarepresentedusingaback-scalingtransformation,asdescribedpreviously(Cloarec etal,2005b),whichallowseachvariable
to be plotted with a color code that relates to the signiﬁcance of class discrimination as calculated from the correlation matrix. Arg, arginine; Asp, aspartate; Asn,
asparagine; CA, cholic acid; Gln, glutamine; Gsh, glutathione; GPC, glycerophosphorylcholine; IAG, indoleacetylglycine; Lys, lysine; Nac, N-acetyl-glycoproteins; PAG,
phenylacetylglycine; TCA, taurocholic acid; TbMCA, Tauro b muricholic acid; TUDCA, tauroursodeoxycholic acid.
Table IV O-PLS-DA model summary for discriminating NMR spectra of plasma,
urine, liver and ileal ﬂushes
Discrimination
analyzed/sample
Conventional versus
re-conventionalized
Conventional versus
HBF
Plasma Q
2Y¼29%, R
2X¼23% Q
2Y¼70%, R
2X¼28%
Urine Q
2Y¼40%, R
2X¼37% Q
2Y¼75%, R
2X¼44%
Liver Q
2Y¼42%, R
2X¼54% Q
2Y¼46%, R
2X¼54%
Ileal ﬂushes Q
2Y o0 Q
2Y¼35%, R
2X¼84%
O-PLS models were generatedwith (1) predictivecomponent and (2) orthogonal
components to discriminate between two groups of mice. The R
2X value shows
how much of the variation in the data set X is explained by the model. The Q
2Y
value represents the predictability of the models and relates to its statistical
validity. A negative value indicates that differences between groups are
statistically nonsigniﬁcant.
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(abbreviation, molecular
weight in g mol–1,
retention time in minutes)
Metabolites
(abbreviation, molecular
weight in g mol–1,
retention time in minutes)
Structure Structure
Cholesterol
(Chol, 386.66)
Cholic acid
(CA, 453.2, 2.92)
Chenodeoxycholic acid
(CDCA, 437.2, 6.63)
Taurocholic acid
(TCA, 514.2, 1.11)
Taurochenodeoxycholoc acid
(TCDCA, 498.2, 1.11)
Glycocholic acid
(GCA, 464.2, 1.69)
Glycochenodeoxycholic acid
(GCDCA, 448.2, 3.29)
Deoxycholic acid
(DCA, 437.2, 7.08)
Taurodeoxycholic acid
(TDCA, 498.2, 1.94)
Glycodeoxycholic acid
(GDCA, 448.2, 3.85)
Glycoursodeoxycholic acid
(GUDCA, 448.2, 1.64)
Lithocholic acid
(LCA, 421.2, 10.86)
Taurolithocholic acid
(TLCA, 482.2, 4.35)
Glycolithocholic-3S acid
(GLCA-3S, 512.2, 2.41)
α-Muricholic acid
(αMCA, 453.2, 1.7)
Tauro-α-muricholic acid
(TαMCA, 514.2, 0.9)
HO
HO
HO
HO
HO
HO
OH O
O
O
O
O
-CO- Taurine
-CO- Taurine
-CO- Glycine
-CO- Taurine
-CO- Glycine
-CO- Taurine
-CO- Glycine
-CO- Taurine
-CO- Taurine
-CO- Glycine
-CO- Taurine
-CO- Glycine
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
OH
HO
HO
HO
HO
HO
O
O
O
O
O
OH
OH
OH
β-Muricholic acid
(βMCA, 453.2, 1.91)
ω-Muricholic acid
(ω MCA, 453.2, 1.91)
Tauro-β-muricholic acid
(TβMCA, 514.2, 1.05)
Hyocholic acid
(λ-Muricholic acid)
(HCA, 453.2, 2.29)
Hyodeoxycholic acid
(HDCA, 437.2, 3.32)
Ursodeoxycholic acid
(UDCA, 437.2, 3.28)
Tauroursodeoxycholic acid
(TUDCA, 498.2, 1.11)
100 0.90 TβMCA
0
100
0
100
0
100
1.70
1.58
1.91 αMCA
ωMCA
βMCA
%
r
e
l
a
t
i
v
e
 
i
n
t
e
n
s
i
t
y
0
0
1.00 1.50 2.00 2.50 3.50
Retention time (min)
4.50 5.50 6.50 3.00 4.00 5.00 6.00 7.00
30
1.09 TCA
1.05 TUDCA
1.69 TCDCA
1.95 TDCA
1.57 GCA
3.29 UDCA
2.90 CA
2.29  HCA
6.63 CDCA 7.08 DCA
7.82
m/z 514.2
m/z 498.2
m/z 464.2
m/z 437.2
m/z 453.2
8.82e3
6.55e3
9.65e3
314
A
B
Figure 4 Structural andfunctional studyof bileacids.Structures ofbileacidsandcholesterol (A), ascharacterizedinthisstudy. Color denotesfamilyofbileacids, that
is,primary(black),secondary(green)andtertiary(orange).Conjugationwithtaurineandglycineiscoloredinblueandredrespectively.Keyintermediatesinthepathway
are colored in gray. Typical negative ion mass chromatograms from the UPLC–MS analysis (B) for the ions detected at the given m/z for the ileal ﬂush from
a conventional mouse with sample injections of 10ml( 1ml for m/z¼514.2). Numbers under the m/z ratios are the total ion counts for that chromatogram.
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(Figure 7C) reveal that microbiome/metabolome bipartite
graphs from HBF mice show in general lower complexity than
conventional mice.In particular, for |r|40.5,weobservedthat
in the conventional ﬂora network of degree 9, the most
connectedbacteriaareLactobacilli(correlatedtoninedifferent
bile acids, Figure 7A). HBF mice are supplemented with one
Lactobacillus strain (Lactobacillus paracasei) for which only
one functional correlation is signiﬁcant, whereas the most
connected bacteria are Enterobacteria (Escherichia coli)
(correlated to three bile acids; Figure 7B).
Discussion
We have investigated the host’s metabolic response to
perturbation of its enteric microbiota at the systems level,
using multiple compartment information deriving from ‘state-
of-the-art’ metabolic proﬁling technologies combined with
novel data analysis methods. A signiﬁcant association
between changes of the gut microbiome and speciﬁc metabo-
types (obtained fromurine, plasma, intact livertissue and ileal
ﬂush) in mice was shown. This study brings further evidence
that gut microbiota modulates the host systemic lipid
metabolism through (i) modiﬁcation of bile acid metabolic
patterns, impacting directly on (ii) emulsiﬁcation and absorp-
tion properties of bile acids and then indirectly on (iii) storage
of fatty acids in liver and (iv) lipoperoxidation through bile
acid signaling properties, as detailed below (Figure 8).
Modulation of bile acid conjugative patterns
by gut microbiota
The various properties of bile acids provide a complex
signaling system in which the gut microﬂora ﬁnely interacts
with the host’s metabolism. Previous analyses in rodents
(Floch, 2002) reported that the liver secretes almost 100%
tauro-conjugated bile acids in the bile (typically 60% TbMCA
Table V Bile acids composition in gut ﬂushes for the different microbiota
Microbiota/bile acids Conventional Re-conventional HBF
DCA 0.770.5 171N D
CDCA 0.570.1 0.270.1 ND
UDCA 0.570.2 0.770.6 ND
CA 17.776.7 12.779.1 0.470.5
oMCA 0.871 0.770.5 ND
aMCA 0.970.7 0.670.5 0.370.2
bMCA 1.671 1.971.4 0.970.7
HCA 0.170.1 0.170.1 ND
GCA 0.370.1 0.170.1 ND
TDCA 0.770.4 0.670.6 ND
TCDCA 1.971.3 1.170.6 3.371
TUDCA 5.572.3 4.770.8 6.671.4
TbMCA 42.674.2 52.477.6 49.674.8
TCA 23.2713.3 22719.4 3873.4
Ratio TCA:CA 1.4 1.7 118.8
Ratio TbMCA:bMCA 24.0 27.7 52.0
NB: Relative composition in bile acids given in percentage of total bile acid
content. Species not detected with UPLC-MS experiment are shown as ND.
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Figure 5 O-PLS-DA coefﬁcient plots derived from the UPLC–MS bile acid composition. O-PLS-DA coefﬁcient plots derived from the bile acid composition obtainedb y
UPLC–MS analysis of ileal ﬂushes, indicating discrimination between conventional (positive) and HBF colonized mice (negative) (A), and partial discrimination between
conventional (positive) and re-conventionalized mice (negative) (B). The color code corresponds to the correlation coefﬁcients of the variables. One predictive and one
orthogonal components were calculated, and the respective (Q
2Y, R
2X) are (89.1%, 80%) and (51.4%, 62%). The O-PLS-DA coefﬁcient plots are presented using
a back-scaling transformation, as described previously (Cloarec et al, 2005b), which allows each variable to be plotted with a color code that relates to the signiﬁcance
of class discrimination as calculated from the correlation matrix.
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conventionalized mice, primary, secondary and tertiary bile
acids are observed as unconjugated, tauro- and glyco-
conjugated species ileal ﬂushes (Table V). These observations
illustrate the ability of ‘healthy and normal’ gut microbiota
(Hooper and Gordon, 2001) to deconjugate bile acids and
modify them as detailed in Figure 1 and previously (De Smet
et al, 1998; Ridlon et al, 2006). The bacterial composition of
HBF implemented in a murine gastrointestinal ecosystem is
similartothatfoundinhumangastrointestinaltracts(Backhed
et al, 2004; Kibe et al, 2005). It is also signiﬁcantly different
from conventional microbiota in terms of bacterial species and
relative composition, that is, higher levels of Enterobacteria
and Bacteroides (Table I). Our results show that signiﬁcant
variations in microbial populations lead to modiﬁcation of bile
acid symbiotic metabolism in the ileal lumen (Figures 3 and 5;
Table V). Furthermore, similar to HBF mice, re-conventiona-
lized mice also show elevated levels of Enterobacteria and
Bacteroides and high concentrations of TbMCA when com-
pared to conventional mice (Figure 5). The deconjugation of
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Figure6 Effectofmajorbileacidsonorgan-speciﬁcmetabolicproﬁles.O-PLScoefﬁcientplotsdescribingcorrelationbetween
1HNMRspectraof
1HMASNMRCPMG
spectra of liver (A, C) and ileal ﬂushes (B, D) and ileal concentrations of cholic acid (A, B) and taurocholic acid (C, D), as measured using UPLC–MS. The O-PLS
coefﬁcientsplotsarepresentedusingaback-scaling transformation, asdescribedpreviously (Cloarec etal,2005b),whichallowseachvariabletobeplottedwithacolor
code that relates to the signiﬁcance of correlation as calculated from the correlation matrix. One predictive and two orthogonal components were calculated; the
respective (Q
2Y, R
2X) are (55%, 39%), (47%, 37%), (36%, 44%) and (21%, 41%). CA, cholic acid; TCA, taurocholic acid.
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Figure 7 Integration of bile acid and fecal ﬂora correlations. The bipartite graphs were derived from correlations between fecal ﬂora and bile acids in each group:
conventional (A) or HBF (B). G¼(N,E) speciﬁes a graph G with N denoting the node set (bile acids) and E the edge set (correlation between bile acids, above a
deﬁnedcutoff,thatis,|r|40.5),whichwasdeﬁnedusingnetworkdegreestatistics(C).Bileacidsandfecalbacteriacorrespondtoblueellipsenodesandgreenrectangle
nodes respectively. Edges are coded according to correlation value: positive and negative correlations are respectively displayed in blue and orange. aMA, a-muricholic
acid; Ba, Bacteroides; Bf, Biﬁdobacteria; bMA, b-muricholic acid; CA, cholic acid; CDCA, chenodeoxycholic acid; Cp, Clostridium perfringens; DCA,
deoxycholic acid; Eb, Enterobacteria; GCA, glycocholic acid; HCA, hyocholic acid; Lb, Lactobacillus; OMA, o-muricholic acid; Sc, Staphylococcus;
TCA, taurocholic acid; TCDCA, taurochenodeoxycholic acid; TDCA, taurodeoxycholic acid; TMCA, tauro-b-muricholic acid; TUDCA, tauroursocholic acid; UDCA,
ursocholic acid.
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synthesized in signiﬁcant amounts by Lactobacillus and
Biﬁdobacteria (De Smet et al, 1998). Alltogether, these
observations suggest that the balance between Lactobacillus
and Biﬁdobacteria and Enterobacteria, Bacteroides might be
essential in the deconjugation of TbMCA.
To investigate transgenomic metabolic interactions, we
show for the ﬁrst time the use of bipartite graphs to display
correlation patterns between fecal ﬂora and bile acids
(Figure 7). These graphs show the ﬁne relationship between
speciﬁc gut microbial population modulation and bile acid
co-metabolism. For instance, the elevated concentrations
of TbMCA in HBF mice correspond to a relative inability of
HBF todeconjugate murinebile acids(Sacquet etal,1984) and
to transform further TbMCA into derivatized bile acids, such
as u `MCA (Sacquet et al, 1979) or HCA (Eyssen et al, 1983)
(Figure 1 and Table V). The overwhelming contrast between
the simplicity of HBF mice and the complexity of conventional
mice bipartite networks (Figure 7) highlights the contrast
between the restrained abilities of the few bacterial strains
composing HBF to transform bile acids, on the one hand, and
the metabolic ﬂexibility of conventional mice, on the other
hand, whereby the conventional murine bacterial strains
communicate with each other and disperse their metabolic
functions to synthesize additional bile acids (DCA, CDCA,
UDCA,oMCA,HCA,GCA,TDCA).Inthisregard,thesynthesis
of oMCA appears as a good example as it can only be achieved
by speciﬁc bacterial strains (Sacquet et al, 1979) or through
bacterial cooperation (Eyssen et al, 1983). In this regard, this
lower complexity of the HBF bipartite network suggests lower
metabolic ﬂexibility and robustness.
The potential role of microbiome in fat
emulsiﬁcation and absorption
We observe a shift in the bile acid pattern towards tauro-
conjugates in HBF, which can be explained by a lower
deconjugation activity from the microbiota. Bile acids are
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Figure 8 Microbe–mammalian metabolic interactions related to bile acid and lipid metabolism. The bacterial reprocessing of the bile acid pool and regulation of bile
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conjugation modiﬁes their hydrophobic/hydrophilic balance,
which directly relates to lipid emulsiﬁcation and eventually
absorption (Armstrong and Carey, 1982; Heuman, 1989;
Heuman et al, 1989). Tauro-conjugation of bile acids reduces
the hydrophobic/hydrophilic ratio and increases their solubi-
lity and lipid emulsiﬁcation. On the contrary, deconjugated
bile acids are less effective in emulsiﬁcation of dietary lipids
and micelle formation (Armstrong and Carey, 1982; Heuman,
1989; Heuman et al, 1989; Narushima et al, 2000; Tannock,
2004). Here, we show that HBF mice have lower levels of CA
and higher levels of TCA and TbMCA (Figures 3 and 5), with
ratios of TCA:CA of 118.8 and TbMCA:bMCA of 52, whereas
conventional mice showed ratios of TCA:CA of 1.4 and
TbMCA:bMCA of 24 (Table V). These biochemical changes
towards increasing lipid emulsion efﬁciency of the bile acid
mixture (Staggers et al, 1982; Watkins, 1985) were also shown
to modify the hepatic phase II taurine conjugation activity as
described by the strong correlation between taurine concen-
tration in the liver and ileal bile acid composition (Figure 6).
This data integration clearly shows two opposite biological
mechanisms: the tauro-conjugation process of CA into TCA in
the liver, which is counterbalanced by a bacteria-mediated
deconjugation process in the intestinal tract (ileum). More-
over, HBF mice show higher urinary excretion of b-alanine,
which is a competitive inhibitor of taurine uptake in kidney
and liveras it shares the same transporter (Bollardet al, 2005).
The differences in b-alanine elimination also illustrate the
different requirements of taurine in the metabolism of bile
acids, which is consistent with higher demands in conven-
tional animals for conjugation of bile salts. Our observations
suggest increased hydrophilicity of the bile acid pool in HBF
and re-conventionalized mice, which would lead to higher
intestinal absorption of dietary lipids and higherenterohepatic
recycling of bile acid pool when compared to conventional
animals.Recentﬁndingssupportourresultswithsuggestionof
the essential microbial role in affecting bile acid-controlled
signaling pathways involved in energy and lipid metabolism
(Houten et al, 2006; Watanabe et al, 2006). In particular,
endogenous bile acids and derivates such as UDCA and
TUDCA were shown to be chemical chaperones (osmolytes)
with antidiabetic properties (Ozcan et al, 2006). Hence, the
perturbation of the microbiota by modifying bile acid
metabolism may ultimately affect the nutritional and wider
health status of the host.
The gut microbiota modulate lipid metabolism
in the host
The essential role of gut microbiota on serum lipid levels in
humans has gained interest recently, in relation to the possible
etiologyofcardiovasculardiseases(PereiraandGibson,2002).
For instance, cholesterol-lowering effects were reported for
Lactobacillus and Biﬁdobacteria, as well as protection against
VLDL and LDL oxidation (Terahara et al, 2000; Xiao et al,
2003). These observations are consistent with previous
ﬁndings that the microbiota promote storage of triglycerides
in adipocytes via indirect modulation of cellular fatty acids
uptake, secretionof apolipoproteinsand adipocyte triglyceride
accumulation (Backhed et al, 2004; Dumas et al, 2006). Lin
et al (1996a,b) and Watanabe et al (2004) demonstrated that
an increase in the intracellular bile acids concentration (in
particular TCA) and decrease in hepatic bile acid synthesis
inhibit the synthesis and secretion of VLDL-associated
triglycerides from hepatocytes as well as the secretion of the
apolipoprotein associated with transport of VLDL, namely
apoB-100. These previous results indicate that bile acids might
play a physiological role in regulating VLDL production by the
liver, the enterohepatic circulation acting as a feedback loop.
This provides a mechanistic model in which the symbiotic
microbiota can modulate the host’s lipid metabolism. The gut
bacterial–mammalian metabolic interactions related to bile
acid and lipid metabolism are summarized in Figure 8.
A microﬂora nonadapted to mice modulates the
physiology of the host towards a pre-pathologic
state
In the present study, mice re-colonized with HBF show
decreased plasma lipoproteins concentration (mainly VLDL
and LDL), increased glycerol, GPC and choline in plasma and
increased hepatic triglyceride concentrations (Figure 3). Our
results suggest that the higher enterohepatic recycling of TCA
and TbMCA associated with higher intestinal absorption of
dietary lipids in HBF mice leads to reduced synthesis and
secretion of VLDL-associated triglycerides, and consequently
accumulation of lipids in the liver and reduction of VLDL and
LDL concentrations in plasma.
Such ﬁndings have to be interpreted simultaneously with
lower concentrations of glutathione observed in the liver from
HBF mice (Figure 3). Glutathione plays important roles in
nutrient metabolism and antioxidant defense: depletion in
glutathione contributes to oxidative stress, involved in the
pathogenesis of several diseases, including cancer, liver
disease, heart attack and diabetes (Wu et al, 2004). Previous
observations reported reduced glutathione levelsin the liverof
rats fed with cholesterol plus cholic acid (Clarke et al, 1976;
Girard et al, 2005), which is consistent with the observed
higher intestinal absorption of dietary lipids and enterohepatic
recycling of bile acid pool in HBF mice. Reprocessing of fatty
acids and subsequent generation of radical oxidative species
result in higher oxidative stress, this situation leading
to peroxidation of hepatic lipids and eventually liver disease
(Wu et al, 2004). Such glutathione depletion can be reached
either by nutritional deﬁciency or by increased glutathione
peroxidaseandglutathionereductaseactivitiesintissues.High
oxidative stress denotes an increased lipoperoxidation risk
(Figure8).Altogether,ourobservationssuggestthatHBFisnot
a sustainable ﬂora for mice, which might result in impaired
liver functions.
In conclusion, both systemic and tissue-speciﬁc metabolic
changes across a wide range of metabolic pathways and
metabolite classes indicate the deep extent of host–microbiota
co-metabolic interactions. This work strongly supports the
idea that several complex metabolic disease traits can be
inﬂuenced by the gut microbiota.
In this study, we have shown that re-conventionalization of
mice normalizes their metabolism towards a healthy physiol-
ogy. This metabolic convergence strikingly contrasts with our
observations in the HBF model. We report that HBF is not a
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the murine host towards a pre-pathologic state. Whereas re-
conventionalized mice evolve to normal gut ﬂora from an
ecological point of view, HBF supplementation maintains the
gut tract and the liver out of a sustainable mouse ecological
equilibrium, as denoted by higher numbers of Clostridium
perfringens (Table I). The metabolic consequences for the host
show an increase in lipid accumulation in liver (despite a
decrease in lipoprotein sub-fractions in blood) associated to a
higher lipoperoxidation risk. We also observed the critical
involvement of the microbiome in supplying host caloriﬁc
requirement via caloric recovery through ﬁbers fermentation.
In this case, gut bacteria exert modulation over the host
metabolism via reprocessing of signaling molecules, that is,
bile acids, that might be involved in common metabolic
diseasessuch asobesityor type II diabetes(Houten et al, 2006;
Ozcan et al, 2006; Watanabe et al, 2006). As such, bile acids
may be an example of transgenomic mechanism of quorum
sensing (Nicholson et al, 2005), whereby microbial cells
communicate with each other and disperse their metabolic
functions, thus behaving like a multicellular organism.
Metabolic proﬁling on conventional mice, compared to HBF
animals, showed that the gut microﬂora are an essential
evolutionary driver towards providing more reﬁned control
mechanisms on the host’s physiology, which ultimately
determine host nutritional status and health. Our results
suggest that controlling the dynamics of the gut microbiome to
maintain or re-establish a balanced and well-adapted micro-
ﬂora could help to prevent some microbial-related metabolic
disorders such as hepato-gastrointestinal diseases.
Materials and methods
Animal handling procedure and probiotic
administration
All animal studies were carried out under appropriate national
guidelines at the Nestle ´ Research Center (Lausanne, Switzerland).
The HBF strains were isolated from stool from a 20-day-old female
baby, who was naturally delivered and breast-fed as described
previously (Guigoz et al, 2002). The HBF ﬂora contained only the
following strains of bacteria: E. coli, Biﬁdobacteria breve, B. longum,
Staphylococcus epidermidis, S. aureus, C. perfringens and Bacteroides.
After 48h at 371C (24h for E. coli, S. aureus and S. epidermidis), the
number of bacteria for each strain was estimated as described
previously (Guigoz et al, 2002) and were mixed at equal amounts
(10
10 cells/ml for each strain) for gavage. Bacterial cell mixtures for
inoculation were kept in frozen aliquots with their spent culture
medium until use. L. paracasei was obtained from the Nestle ´ Culture
Collection (Lausanne, Switzerland) and grown under anaerobic
conditions in Man-Rogosa-Sharpe (MRS) culture medium.
A total of 26 C3H female mice, aged 6 weeks, were fed with a
standard pathogen-free rodent diet (Nestle ´, Switzerland). A group of
conventional mice was kept as control (n¼9). One group of germfree
mice was re-conventionalized by removal from their germfree isolator
andexposuretonormalenvironmentforaperiodof4weeks(n¼10).A
second group of germfree mice received a single dose of HBF (n¼7) by
oralgavageand2weekslater,theyweregivenL.paracaseiprobioticby
mixing aliquots of 1ml probiotics (4 10
9cells/ml) with 200ml of
saline under pathogen-free conditions for a period of 2 weeks. As each
mouse drinks on average 5ml/day, each mouse received around 10
8
probiotic bacteria per day, which allows maintaining the probiotic
population in a steadystatewithinthe gut environment. Animalswere
euthanized after 4 weeks and microbial analysis was carried out on
fecal samples as described previously (Guigoz et al, 2002). Urine was
collected from mice before killing upon holding them by immobiliza-
tion grip and urine was snap-frozen immediately. Blood (400ml) was
collected into Li-heparin tubes and the plasma was obtained after
centrifugation and frozen at  701C. The liver was dissected and snap-
frozen. The intestine from the stomach to the cecum was removed
from each animal. The ﬁrst 1cm length after the stomach was
considered to be duodenum and the rest was divided into three
sections: the ﬁrst 2/3 was designated as jejunum and the remaining
1/3 as ileum. Three-centimeter samples (3cm) were excised from the
middle of each section. Ileal ﬂush samples were obtained by rinsing
the ileal lumen with 1ml of a phosphate buffer solution (0.2M
Na2HPO4/0.04M NaH2PO4 (pH 7.4)) using a 1-ml sterile syringe.
Samples were retrieved in Eppendorf tubes and snap-frozen before
NMR spectroscopy and UPLC–MS analyses. Samples included ﬁve
ﬂush samples from conventional and re-conventionalized mice and
seven ﬂush samples from HBF colonized mice. Cecal content was
collected upon animal autopsy, snap-frozen immediately and kept at
 801C before analysis.
Microbial proﬁling of fecal contents
Brieﬂy, for each mouse, one fecal pellet was homogenized in 0.5ml
Ringer solution (Oxoid, UK) supplemented with 0.05% (w/v)
L-cysteine (HCl), and different dilution of the bacterial solution were
plated on selective and semiselective media for the enumeration of
speciﬁc microorganisms: Biﬁdobacteria on Eugom Tomato medium,
Lactobacillus on Man, Rogosa and Sharpe (MRS)þantibiotics
(phosphomycine, sulfamethoxazole and trimethoprime) medium,
C. perfringens on NN-agar medium, Enterobacteriaceae on Drigalski
medium and Bacteroides on Shaedler Neo Vanco medium (Guigoz
etal,2002).Plateswereincubatedat371Cunderaerobicconditionsfor
24h for the counting of Enterobacteriaceae, and under anaerobic
conditions during 48h for Biﬁdobacteria, Lactobacillus, Bacteroides
and C. perfringens.
Gas chromatography analysis of cecal contents
Fecal SCFAs in cecumwere analyzedusing gas chromatography ﬂame-
ionization-detection (GC-FID). An aliquot of cecal content was
extracted with 4ml buffer (0.1% (w/v) HgCl2 and 1% (v/v) H3PO4)
supplemented with 0.045mg/ml 2,2-dimethylbutyric acid (as internal
standard) per gram fresh weight. The resulting slurry was centrifuged
for 30min at 5000g at 41C, and the SCFAs in the supernatant collected
were analyzed using a GC (HP 6890) equipped with ﬂame ionization
detector(FID)andaDB-FFAPcolumn(J&WScientiﬁc,MSPFriedliand
Co., Switzerland) of 30m length, 530mm diameter and 1mm ﬁlm
thickness. The system was run with helium gas at an inlet constant
pressure of 10psi at 1801C. Each sample run was preceded with a
cleaning injection of 1.2% formic acid. Samples were run at an initial
temperature of 801C for 1.2min, then at 1451C for 6.5min,at 2001C for
0.55minandat2001Cfor0.5min.SCFAswereidentiﬁedusingexternal
standards consisting of authentic acetate, propionate, iso-butyrate,
n-butyrate, iso-valerate and n-valerate, and the concentration was
calculated using internal standard.
1H NMR spectroscopic analysis
Plasma samples were prepared by adding saline solution containing
10% D2O(serving asa spectrometerﬁeld frequency lock)into 100mlo f
blood plasma to a total volume of 550ml. Urine samples were prepared
by mixing 20ml of samples with 30ml of a deuterated phosphate buffer
solution (90% D2O, 10% H2O) containing 0.25mM 3-trimethylsilyl-1-
[2,2,3,3-
2H4] propionate (TSP) as chemical shift reference (d 0.0). Ileal
ﬂushes were sonicated at ambient temperature (298K) for 30min to
destroy bacterial cells and then centrifuged at 13000r.p.m. for 15min.
Aliquotsof 300ml weremixed with300ml ofa solutioncontaining90%
D2O and 0.25mM TSP. Intact liversamples werebathed in 0.9% saline
D2O solution. A portion of the tissue (B15mg) was inserted into a
zirconium oxide 4mm outer diameter rotor, using an insert to make
a spherical sample volume of 25ml.
All
1H NMR spectra were recorded on a Bruker DRX 600 NMR
spectrometer (Rheinstetten, Germany) operating at 600.11MHz for
1H
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1H NMR spectra of plasma, urine and ileal ﬂushes were
acquired with a Bruker 5mm TXI triple resonance probe at 298K.
1H
NMR spectra of intact liver tissues were acquired under magic-angle-
spinning conditions at a spin rate of 5000Hz (Waters et al, 2000).
Tissue samples were regulated at 283K using cold N2 gas during the
acquisition of the spectra to minimize any time-dependent biochem-
ical degradation.
1D
1H NMR spectra were obtained from each sample using a
standard solvent suppression pulse sequence (RD-901-t1-901-tm-901-
acquire FID) with tm ﬁxed at 100ms and t1 at 3ms (Wang et al, 2005).
Additional 1D Carr-Purcell-Meiboom-Gill (CPMG) spectra were
acquired for plasma and liver samples. CPMG spectra were acquired
using the pulse sequence (RD-901-(t-1801-t)n-acquire FID), with a
spin–spin relaxation delay, 2nt, of 160ms for plasma and 200ms for
tissue (Stejskal and Tanner, 1965). The 901 pulse length was9.0–12ms.
A total of 128 transients were collected into 32K data points with a
pulse recycle delay (RD) of 2s.
For assignment purposes, 2D COSY (Nagayama, 1980) and TOCSY
(Bax and Davis, 1985) NMR spectra were acquired on selected
samples.Furtherassignmentofthemetaboliteswasalsoaccomplished
with the use of STOCSYon 1D spectra (Cloarec et al, 2005a).
UPLC–MS materials and methods
TheUPLCofilealﬂusheswasperformedonaACQUITYUPLCtsystem
(Waters, Milford, MA, USA). Mass Spectrometry was performed on a
TOFt LCT-Premier (Waters MS Technologies, Manchester, UK). Flush
samples were ﬁrst freeze-dried before being diluted to a ﬁnal
concentration of 1mg/ml with a 1:1 acetonitrile/water solution.
Samples were maintained at 41C, and 10 and 1ml injections were made
into a 10cm 2.1mm ACQUITYt BEH C18 1.7mm UPLC column
(Waters) maintained in an oven at 401C. The bile acids eluted under
gradient conditions at a ﬂow rate of 500ml/min from aceto-
nitrile:water¼40:60 to 60:40 over 12min (pH 4).
The Q-TOF mass spectrometer was operated in W-optic path and
negative ion mode with a capillary voltage of 2.6kV, cone voltage of
50V, nebulizer gas ﬂow of 600l/h, desolvation temperature of 3001C
and a source temperature of 1001C. All analyses were acquired using
the lock-spray to ensure mass accuracy and reproducibility, and
leucine-enkephalin was used as the lock mass (m/z 554.2615) at a
concentration of 200ng/ml and a ﬂow rate of 20ml/min. Data were
collected over 12min in centroid mode with a lock-spray frequency of
11s over the mass range m/z 50–850 with an acquisition time
of 250ms,aninterscan delayof50msand dataaveragingover10 scans.
The standards used as bile acid reference materials are listed in
Figure4withtheabbreviations,molecularstructure,molecularweight
and the retention time observed using this UPLC–MS method.
Data preparation
1H NMR spectra were manually phased and baseline-corrected using
XwinNMR 3.5 (Bruker Biospin, Rheinstetten, Germany) and referenced
to the chemical shift of the CH3 resonance of alanine at d 1.466. The
regions containing the water resonance (d 4.5–5.19), and for urine urea
resonance (d 4.5–6.2), were removed. The spectra were converted into
22Kdatapointsovertherangeofd0.2–10.0usinganin-house-developed
MATLAB routine (Dr O Cloarec, personal communication). The spectra
were normalized to a constant sum before chemometric analyses.
UPLC–MS data were processed using the Micromass MarkerLynxt
applications manager Version 4.0 (Waters). The peaks of bile acids
were identiﬁed by comparison to the m/z ratio and retention time of a
set of standard bile acids (Figure 4). Integration of the UPLC–MS bile
acid peaks was performed using ApexTrack2t peak detection
(Waters). Data were noise-reduced in both the UPLC and MS domains
using MarkerLynxt. The ion intensities for each bile acid identiﬁed
were normalized, within each sample, to the sum of the peak
intensities in that sample.
Chemometrics: modeling and interpretation
Statistical analysis of the changes in bacterial populations and in the
fecalcompositioninSCFAsobtainedbyGC-FIDwascarriedoutusinga
two-tailed Mann–Whitney test.
The multivariate pattern recognition techniques used in this study
were based on orthogonal projection to latent structure (O-PLS)
approachwithunit-variancescaling(TryggandWold,2003).InO-PLS-
DA algorithm, the variation in X (NMR spectra or ion counts) is
decomposed into three parts: ﬁrst, the variation in X (the data matrix)
related to Y (the class matrix), and the two last parts contain the
speciﬁc systemic variation in X and residual, respectively (Trygg and
Wold, 2003). This leads to a model with a minimal number of
predictive components deﬁned by the number of degrees of freedom
between group variances. The O-PLS coefﬁcient (covariance) plots are
presented using a back-scaling transformation, which preserves the
original spectral structure appearance for NMR data (Cloarec et al,
2005b). This also allows each data variable to be plotted with a color
code, which relates to the signiﬁcance of class discrimination as
calculated from the correlation matrix. The covariance and correlation
correspondtotheshapeandcolorcoderespectively.Here,acoefﬁcient
of r¼0.57 was determined according to the test for the signiﬁcance of
the Pearson’s product-moment correlation coefﬁcient as the cutoff
value, which was calculated based on discrimination signiﬁcance at
the level of Po0.05. The standard seven-fold cross-validation method
was applied to establish the robustness of the model (Holmes et al,
2006).
Bipartite graph representation bile acid and fecal
ﬂora proﬁles
To explore the possible transgenomic interactions between gut
microbes and the host’s metabolism, functional correlation networks
were derived from bile acid and fecal ﬂora proﬁles correlation
coefﬁcients using the bipartite graph Rgraphsviz package from R to
represent the correlation matrix. Pearson’s correlation coefﬁcients
were computed between bile acid variables and fecal ﬂora variables
from the sameanimals. Acutoff was thenappliedtothe absolutevalue
of the coefﬁcient |r|, so that absolute correlations |r|4cutoff were set
to 1 and absolute correlations |r|ocutoff were set to 0, thus deﬁning
the adjacency matrix for the graph (deﬁning connections between
entities). Hence, G¼(N, E) speciﬁes a graph G with N denoting the two
nodesets(twotypesofnodes: bileacidsand fecalﬂora) andE the edge
set(linkbetweennodes,hereacorrelationbetweenbileacidsandfecal
ﬂora above the cutoff, i.e. |r|40.5). The bipartite graph represents
only the correlations between the two types of nodes (fecal ﬂora and
bile acids). In that context, presence of edges between two speciﬁc
nodes (one of each type) reveals a functional correlation (above the
cutoff) between these two entities. On the graph, the edges were then
color-coded to represent the sign of the initial correlation (blue
negative, orange positive) and the correlation value was displayed. To
assess the pattern of correlations between fecal ﬂora and bile acids,
several correlation cutoff values were tested. For each correlation
cutoff value, the number of edges connected to each was then
computed to assess the degree of the network (number of edges
connected to the most connected node).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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